earnings

Ionis Pharmaceuticals Funds Its Pipeline of More Than 40 Drugs
Ionis Pharmaceuticals Funds Its Pipeline of More Than 40 Drugs
Motley Fool
Ionis Pharmaceuticals
earnings
Flag link:
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs
Yahoo/Benzinga
IPOs
biotech
JNJ
Janssen
esketamine
Shockwave Medical
earnings
Sensen Bio
MyoKardia
Flag link:
Why Diabetes Stock Insulet Jumped 15.7% in February
Why Diabetes Stock Insulet Jumped 15.7% in February
Motley Fool
Insulet
devices
earnings
insulin pumps
Flag link:
Momenta Continues to Rebuild
Momenta Continues to Rebuild
Motley Fool
Momenta Pharmaceuticals
earnings
Flag link:
Clovis (CLVS) Q4 Earnings Lag Estimates, Rubraca Sales Recover
Clovis (CLVS) Q4 Earnings Lag Estimates, Rubraca Sales Recover
Yahoo/Zacks.com
Clovis Oncology
earnings
Flag link:
What's Behind Mylan's Disappointing Q4 Earnings?
What's Behind Mylan's Disappointing Q4 Earnings?
Motley Fool
Mylan
earnings
Flag link:
MannKind (MNKD) Q4 Revenues Rise 254%; Achieves First Ever Qtr Afrezza Gross Profit
MannKind (MNKD) Q4 Revenues Rise 254%; Achieves First Ever Qtr Afrezza Gross Profit
Street Insider
MannKind
earnings
Afrezza
Flag link:
Emergent BioSolutions Looks to Break $1 Billion
Emergent BioSolutions Looks to Break $1 Billion
Motley Fool
Emergent BioSolutions
earnings
Flag link:
Exact Sciences Hit a Home Run in Q4. Here's Why Sales Could Soon Soar Even More
Exact Sciences Hit a Home Run in Q4. Here's Why Sales Could Soon Soar Even More
Yahoo/Motley Fool
EXACT Sciences
earnings
Cologuard
Flag link:
bluebird (BLUE) Q4 Earnings Beat Estimates, Revenues Up Y/Y
bluebird (BLUE) Q4 Earnings Beat Estimates, Revenues Up Y/Y
Yahoo/Zacks.com
Bluebird Bio
earnings
Flag link:
Alkermes Breaks $1 Billion
Alkermes Breaks $1 Billion
Motley Fool
Alkermes
earnings
Flag link:
Teva (TEVA) Q4 Earnings Miss,'19 View Weak, Shares Down
Teva (TEVA) Q4 Earnings Miss,'19 View Weak, Shares Down
Yahoo/Zacks.com
Teva Pharmaceutical
earnings
Flag link:
AstraZeneca's (AZN) Q4 Earnings Beat, New Drugs Drive Sales
AstraZeneca's (AZN) Q4 Earnings Beat, New Drugs Drive Sales
Yahoo/Zacks.com
earnings
AstraZeneca
Flag link:
Teva (TEVA) to Report Q4 Earnings: What's in the Cards?
Teva (TEVA) to Report Q4 Earnings: What's in the Cards?
Yahoo/Zacks.com
Teva Pharmaceutical
earnings
Flag link:
Here's Why AbbVie's Stock Tanked in January
Here's Why AbbVie's Stock Tanked in January
Motley Fool
AbbVie
earnings
Flag link:
Exelixis (EXEL) to Report Q4 Earnings: What's in Store?
Exelixis (EXEL) to Report Q4 Earnings: What's in Store?
Yahoo/Zacks.com
Exelixis
earnings
Flag link:
Sanofi (SNY) Q4 Earnings Top, Genzyme Unit Drives Sales Growth
Sanofi (SNY) Q4 Earnings Top, Genzyme Unit Drives Sales Growth
Yahoo/Zacks.com
Sanofi
earnings
Flag link:
Glaxo (GSK) Beats on Q4 Earnings, to Focus on Oncology in '19
Glaxo (GSK) Beats on Q4 Earnings, to Focus on Oncology in '19
Yahoo/Zacks.com
GSK
earnings
Flag link:
Successful launch bolsters Libtayo's place as cornerstone therapy for Regeneron
Successful launch bolsters Libtayo's place as cornerstone therapy for Regeneron
Biopharma Dive
Regeneron
Libtayo
earnings
CSCC
drug launches
Flag link:
Eli Lilly Misses Q4 Earnings, Cuts 2019 Outlook After Loxo Oncology Deal
Eli Lilly Misses Q4 Earnings, Cuts 2019 Outlook After Loxo Oncology Deal
TheStreet.com
Eli Lilly
earnings
M&A
Loxo Oncology
Flag link:

Pages